Contract for the supply of meningococcal group B vaccine (2022)

The provision of a vaccine to protect against meningococcal B, to be used in the national childhood immunisation programme. Deliveries will be required over the initial term of 3 years and the contract has the option to be extended for up to an additional 12 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.